Methods of reducing the risk of cardiovascular events in a subject

MD3750536T2Active Publication Date: 2026-06-30AMARIN PHARMACEUTICALS IRELAND LIMITED(IE)

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: MD · MD
Patent Type: Patents
Current Assignee / Owner: AMARIN PHARMACEUTICALS IRELAND LIMITED(IE)
Filing Date: 2019-04-22
Publication Date: 2026-06-30

Application Information

Patent Timeline

22 Apr 2019

Application

30 Jun 2026

Publication

MD3750536T2

IPC: A61K31/232; A61K31/202; A61K31/366; A61K31/40; A61K31/505; A61K45/06; A61P9/00; A61P9/10

CPC: A61K31/202; A61K31/232; A61P9/00; A61P9/10; A61K31/40; A61K31/505; A61K31/366; A61K45/06

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Patent Text Reader

Abstract

In various embodiments, the present disclosure provides methods of reducing the risk of cardiovascular events in a subject on statin therapy by administering to the subject a pharmaceutical composition comprising about 1g to about 4g of eicosapentaenoic acid ethyl ester or a derivative thereof.

Need to check novelty before this filing date? Find Prior Art